Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Treatment of poor prognosis metastatic teratoma
ISRCTN ISRCTN14535482
DOI 10.1186/ISRCTN14535482
ClinicalTrials.gov identifier
EudraCT number
Public title Treatment of poor prognosis metastatic teratoma
Scientific title
Acronym N/A
Serial number at source TE13
Study hypothesis Determine whether treatment with the intensive regimen BOP/VIP-B is more effective than BEP/P.
To determine the effect of G-CSF on the proportion of patients receiving full dose intensity of combination chemotherapy with either regimen.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Metastatic teratoma
Participants - inclusion criteria Histologically proven non-seminomatous germ cell tumour
Participants - exclusion criteria Previous radiotherapy or chemotherapy
Anticipated start date 01/02/1991
Anticipated end date 31/12/1994
Status of trial Completed
Patient information material
Target number of participants 154
Interventions Arm 1 - Without granulocyte colony stimulating factor (G-CSF), BEP/EP.
Arm 2 - Without G-CSF, BOP/VIP-B.
Arm 3 - With G-CSF, BEP/EP.
Arm 4 - With G-CSF, BOP/VIP-B.
Primary outcome measure(s) Progression-free survival
Secondary outcome measure(s) Response rate, overall survival
Sources of funding Medical Research Council (MRC) (UK)
Trial website
Publications
Contact name Miss  Sharon  Naylor
  Address MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Email
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 28/02/2001
Last edited 31/01/2013
Date ISRCTN assigned 28/02/2001
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.